Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.

about

Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.

P2860

Q45985720-6BA62E66-3453-40AF-9123-E99C935BEFA2 Q50026332-1B0A5D0A-B2AF-465E-8F52-A3211516C578

P2860

Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.

Item

http://www.wikidata.org/entity/Q39120033

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.

@en

Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.

@nl

type

Item

label

Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.

@en

Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.

@nl

prefLabel

Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.

@en

Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.

@nl

P1476

Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.

@en

P2093

Nabeel Khan

http://www.w3.org/2001/XMLSchema#string

Umar Darr

http://www.w3.org/2001/XMLSchema#string

P2860

Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Crohn's disease

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.

Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease

Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity.

Clinical prognostic factors for disabling Crohn's disease: a systematic review and meta-analysis.

Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis.

The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.

Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease.

P2888

s11938-017-0130-6

P304

116-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11938-017-0130-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28161818

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.

about

P2860

P2860

Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921